Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer.
de Roest RH, van der Heijden M, Wesseling FWR, de Ruiter EJ, Heymans MW, Terhaard C, Vergeer MR, Buter J, Devriese LA, de Boer JP, Navran A, Hoeben A, Vens C, van den Brekel M, Brakenhoff RH, Leemans CR, Hoebers F. de Roest RH, et al. Among authors: de boer jp. Radiother Oncol. 2022 Oct;175:112-121. doi: 10.1016/j.radonc.2022.08.013. Epub 2022 Aug 13. Radiother Oncol. 2022. PMID: 35973619 Free article.
Five-year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra-arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer.
Ackerstaff AH, Rasch CR, Balm AJ, de Boer JP, Wiggenraad R, Rietveld DH, Gregor RT, Kröger R, Hauptmann M, Vincent A, Hilgers FJ. Ackerstaff AH, et al. Among authors: de boer jp. Head Neck. 2012 Jul;34(7):974-80. doi: 10.1002/hed.21851. Epub 2011 Aug 4. Head Neck. 2012. PMID: 21818820 Clinical Trial.
Long-term hearing loss after chemoradiation in patients with head and neck cancer.
Theunissen EA, Zuur CL, Bosma SC, Lopez-Yurda M, Hauptmann M, van der Baan S, de Boer JP, van der Molen L, Rasch CR, Dreschler WA, Balm AJ. Theunissen EA, et al. Among authors: de boer jp. Laryngoscope. 2014 Dec;124(12):2720-5. doi: 10.1002/lary.24802. Epub 2014 Jun 26. Laryngoscope. 2014. PMID: 24964759
Late follow-up of the randomized radiation and concomitant high-dose intra-arterial or intravenous cisplatin (RADPLAT) trial for advanced head and neck cancer.
Heukelom J, Lopez-Yurda M, Balm AJ, Wijers OB, Buter J, Gregor T, Wiggenraad R, de Boer JP, Tan IB, Verheij M, Sonke JJ, Rasch CR. Heukelom J, et al. Among authors: de boer jp. Head Neck. 2016 Apr;38 Suppl 1:E488-93. doi: 10.1002/hed.24023. Epub 2015 Jul 6. Head Neck. 2016. PMID: 25728984 Clinical Trial.
Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands.
van der Linden N, Buter J, Pescott CP, Lalisang RI, de Boer JP, de Graeff A, van Herpen CM, Baatenburg de Jong RJ, Uyl-de Groot CA. van der Linden N, et al. Among authors: de boer jp, de graeff a. Eur Arch Otorhinolaryngol. 2016 Feb;273(2):455-64. doi: 10.1007/s00405-015-3495-y. Epub 2015 Jan 21. Eur Arch Otorhinolaryngol. 2016. PMID: 25876000 Free PMC article.
Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy.
Theunissen EA, Zuur CL, Józwiak K, Lopez-Yurda M, Hauptmann M, Rasch CR, van der Baan S, de Boer JP, Dreschler WA, Balm AJ. Theunissen EA, et al. Among authors: de boer jp. JAMA Otolaryngol Head Neck Surg. 2015 Sep;141(9):810-5. doi: 10.1001/jamaoto.2015.1515. JAMA Otolaryngol Head Neck Surg. 2015. PMID: 26291150
Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trial.
Driessen CML, Groenewoud JMM, de Boer JP, Gelderblom H, van der Graaf WTA, Prins JB, Kaanders JHAM, van Herpen CML. Driessen CML, et al. Among authors: de boer jp. Support Care Cancer. 2018 Apr;26(4):1233-1242. doi: 10.1007/s00520-017-3946-7. Epub 2017 Dec 11. Support Care Cancer. 2018. PMID: 29230548 Free PMC article. Clinical Trial.
116 results